KIT mutations in ocular melanoma: frequency and anatomic distribution (Q44394005)

2 December 2017

KIT mutations in ocular melanoma: frequency and anatomic distribution (English)

1 reference

2 December 2017

1 reference

2

Lester J Layfield

1 reference

2 December 2017

Michelle L Wallander

1

1 reference

2 December 2017

Lyska L Emerson

3

1 reference

2 December 2017

Nick Mamalis

4

1 reference

2 December 2017

Don Davis

5

1 reference

2 December 2017

Sheryl R Tripp

6

1 reference

2 December 2017

Joseph A Holden

7

1 reference

2 December 2017

8 April 2011

1 reference

2 December 2017

1 reference

2 December 2017

24

1 reference

2 December 2017

8

1 reference

2 December 2017

1031-1035

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2011.57

2 December 2017

0 references

cites work

Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

KIT gene mutations and copy number in melanoma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Somatic activation of KIT in distinct subtypes of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Major response to imatinib mesylate in KIT-mutated melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Phase II trial of imatinib mesylate in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Tyrosine kinase activating mutations in human malignancies: implications for diagnostic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

KIT as a therapeutic target in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Expression of the c-kit receptor in choroidal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

The role of c-kit and imatinib mesylate in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

C-KIT and PDGFRA zygosity in gastrointestinal stromal tumors: Correlation with tumor site, tumor size, exon, and CD117 immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Low incidence of KIT gene mutations and no PDGFRA gene mutations in primary cutaneous melanoma: an immunohistochemical and molecular genetic study of Japanese cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

Kit and melanocyte migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

inferred from DOI database lookup

7 January 2021

based on heuristic

BRAF and c-kit gene copy number in mutation-positive malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

inferred from DOI database lookup

7 January 2021

based on heuristic

Absence of PDGFRA mutations in primary melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.57

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.2011.57

1 reference

2 December 2017

1 reference